SOPHiA GENETICS S.A.

NASDAQ:SOPH

Medical - Healthcare Information Services

Healthcare
$7.47 +0.38%

+$0.02 today

Market cap
$635.90M
Beta
0.98
P/E (TTM)
-4.6
EPS (TTM)
-$1.14
52W Low $2.59High $5.70

Volume 0.61M

Average 0.10M

SOPH Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

SOPHiA GENETICS S.A.NASDAQ: SOPH

Weighted Avg Shares (Diluted) · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q1 FY2026 weighted avg shares (diluted) of 71.14M shares rose 6.4% year over year, ahead of the +3.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it rose 4.2% from the prior quarter. Over 3 fiscal years it compounded at +1.8% a year.

Context

  • Weighted avg shares (diluted) increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +6.4% holds above the trailing-twelve-month pace of +3.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
71.14M+4.2% QoQ
Last fiscal yearDec 2025
67.54M+2.7% YoY
LTMMar 2026
68.62M+3.6% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.4%——
1 year+2.7%——
3-year CAGR+1.8%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
67.54M USD
Year-over-year change
+2.7%
4-year CAGR
+5.1%

Weighted Avg Shares (Diluted) vs competitors

How SOPH compares with its peers on the latest reported figures

  • SOPH's LTM Mar 2026 weighted avg shares (diluted) of 68.62M shares is the 6th highest of the 10 companies compared; the peer median is 70.9M shares.
  • Its year-over-year change of +3.6% is the 6th highest of 10, against a peer median of +3.7%.
  • Over three fiscal years its annual growth of +1.8% compares with a peer median of +1.3%.
SOPH Competitors Peer median
Weighted Avg Shares (Diluted) for SOPH and competitors
Company Period LTM YoY 3-year CAGR
TEMTempus AI, Inc.LTM Sep 2026179.23M +5.3%+0.9%
CERTCertara, Inc.LTM Mar 2026159.92M -0.6%+0.2%
DHDefinitive Healthcare Corp.LTM Mar 2026104.66M -9.4%+1.8%
PSNLPersonalis, Inc.LTM Mar 202693.42M +36.5%+25.0%
HCATHealth Catalyst, Inc.LTM Mar 202670.9M +13.1%+8.9%
SOPHSOPHiA GENETICS S.A.LTM Mar 202668.62M +3.6%+1.8%
BLLNBillionToOne, Inc.LTM Jun 202649.5M +10.7%—
HSTMHealthStream, Inc.LTM Mar 202629.85M -2.4%-0.6%
NRCNational Research CorporationLTM Mar 202622.24M -5.4%-3.7%
OPRXOptimizeRx CorporationLTM Mar 202619.05M +3.7%+2.2%
Peer median (excluding SOPH) 70.9M+3.7%+1.3%

Competitors are the stored peer set for SOPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue40.45M47.56M62.37M65.17M77.27M
Cost of Revenue15.23M16.31M19.46M21.24M29.46M
Gross Profit25.22M31.25M42.91M43.94M47.81M
Gross Margin62.4%65.7%68.8%67.4%61.9%
Research & Development26.58M35.37M36.97M34.37M33.57M
Selling, General & Admin70.24M84.08M81.72M76.32M85.17M
Operating Expenses96.71M119.08M117.74M110.51M118.74M
Depreciation & Amortization3.61M5.57M8.34M8.6M9.53M
EBITDA(69.24M)(81.38M)(69.57M)(50.76M)(64.4M)
EBITDA Margin-171.2%-171.1%-111.5%-77.9%-83.3%
Operating Income(71.49M)(87.82M)(74.83M)(66.57M)(70.93M)
Operating Margin-176.7%-184.7%-120.0%-102.1%-91.8%
Interest Income20K1.32M4.55M3.36M1.87M
Interest Expense658K639K588K1.91M4.55M
Other Income / Expenses(2.02M)238K(3.67M)5.3M(7.56M)
Income Before Tax(73.51M)(87.59M)(78.5M)(61.27M)(78.49M)
Pre-Tax Margin-181.7%-184.2%-125.9%-94.0%-101.6%
Income Tax Expense168K(136K)486K1.22M512K
Net Income(73.68M)(87.45M)(78.98M)(62.49M)(79M)
Net Margin-182.1%-183.9%-126.6%-95.9%-102.2%
EPS (Basic)(1.33)(1.36)(1.22)(0.95)(1.17)
EPS (Diluted)(1.33)(1.36)(1.22)(0.95)(1.17)
Weighted Avg Shares55.3M64.1M64.75M65.78M67.54M
Weighted Avg Shares (Diluted)55.3M64.1M64.75M65.78M67.54M

SOPHiA GENETICS S.A.

NASDAQ:SOPH

Intrinsic Alpha fair value

Locked

Current Price

$7.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.